Publicaciones en colaboración con investigadores/as de Universidad Europea de Madrid (10)

2023

  1. Audiovestibular Manifestations in Patients with Primary Raynaud’s Phenomenon and Raynaud’s Phenomenon Secondary to Systemic Sclerosis

    Journal of Clinical Medicine, Vol. 12, Núm. 9

2021

  1. Influence of prognosis factors on the prescription of targeted treatments in rheumatoid arthritis: A Delphi survey

    Joint Bone Spine, Vol. 88, Núm. 4

2020

  1. Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology

    Reumatologia Clinica, Vol. 16, Núm. 5, pp. 373-377

  2. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus

    Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224

2018

  1. Biologic Disease-modifying antirheumatic drug attributes in the first lines of treatment of rheumatoid arthritis. 2015 ACORDAR project

    Reumatologia Clinica, Vol. 14, Núm. 2, pp. 90-96

  2. Recommendations for the use of parenteral methotrexate in rheumatic diseases

    Reumatologia Clinica, Vol. 14, Núm. 3, pp. 142-149

  3. Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence

    Rheumatology International, Vol. 38, Núm. 12, pp. 2289-2296

2016

  1. Evaluation of the impact of nursing clinics in the rheumatology services

    Rheumatology International, Vol. 36, Núm. 9, pp. 1309-1317

2015

  1. Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

    Rheumatology (United Kingdom), Vol. 54, Núm. 7, pp. 1200-1209

2014

  1. Osteonecrosis de los maxilares relacionada con el tratamiento con bifosfonatos

    Semergen, Vol. 40, Núm. 3, pp. 143-148